Biotechnology Ultrasector Profund Fund Analysis

BIPIX Fund  USD 67.49  0.29  0.43%   
Below is the normalized historical share price chart for Biotechnology Ultrasector Profund extending back to August 04, 2000. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Biotechnology Ultrasector stands at 67.49, as last reported on the 14th of February 2026, with the highest price reaching 67.49 and the lowest price hitting 67.49 during the day.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Biotechnology Ultrasector's financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. Biotechnology Ultrasector's financial risk is the risk to Biotechnology Ultrasector stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Given that Biotechnology Ultrasector's debt-to-equity ratio measures a Mutual Fund's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Biotechnology Ultrasector is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Biotechnology Ultrasector to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Biotechnology Ultrasector is said to be less leveraged. If creditors hold a majority of Biotechnology Ultrasector's assets, the Mutual Fund is said to be highly leveraged.
Biotechnology Ultrasector Profund is fairly valued with Real Value of 67.59 and Hype Value of 67.49. The main objective of Biotechnology Ultrasector fund analysis is to determine its intrinsic value, which is an estimate of what Biotechnology Ultrasector Profund is worth, separate from its market price. There are two main types of Biotechnology Mutual Fund analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic stability of Biotechnology Ultrasector Profund. On the other hand, technical analysis, focuses on the price and volume data of Biotechnology Mutual Fund to identify patterns and trends that may indicate its future price movements.
The Biotechnology Ultrasector mutual fund is traded in the USA on NMFQS Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotechnology Ultrasector Profund. Also, note that the market value of any mutual fund could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Biotechnology Mutual Fund Analysis Notes

The fund generated returns of 9.0% over the last ten years. Biotechnology Ultrasector holds about 24.54% of assets under management (AUM) in cash. Large For more info on Biotechnology Ultrasector Profund please contact the company at 888-776-3637.

Biotechnology Ultrasector Investment Alerts

The fund holds about 24.54% of its assets under management (AUM) in cash

Biotechnology Ultrasector Thematic Classifications

In addition to having Biotechnology Ultrasector mutual fund in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Tech Funds Idea
Tech Funds
Funds investing in technology

Top Biotechnology Ultrasector Profund Mutual Fund Constituents

Biotechnology Ultrasector Outstanding Bonds

Biotechnology Ultrasector issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Biotechnology Ultrasector uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Biotechnology bonds can be classified according to their maturity, which is the date when Biotechnology Ultrasector Profund has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Biotechnology Ultrasector Predictive Daily Indicators

Biotechnology Ultrasector intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Biotechnology Ultrasector mutual fund daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Biotechnology Ultrasector Forecast Models

Biotechnology Ultrasector's time-series forecasting models are one of many Biotechnology Ultrasector's mutual fund analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Biotechnology Ultrasector's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Biotechnology Ultrasector Assets Financed by Debt

Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Biotechnology Ultrasector's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Biotechnology Ultrasector, which in turn will lower the firm's financial flexibility.

Biotechnology Ultrasector Corporate Bonds Issued

About Biotechnology Mutual Fund Analysis

Mutual Fund analysis is the technique used by a trader or investor to examine and evaluate how Biotechnology Ultrasector prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Biotechnology shares will generate the highest return on investment. We also built our fund analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Fund such as Biotechnology Ultrasector. By using and applying Biotechnology Mutual Fund analysis, traders can create a robust methodology for identifying Biotechnology entry and exit points for their positions.
The index is designed to measure the performance of biotechnology companies included in the SP Total Market Index. Under normal circumstances, the fund will obtain leveraged exposure to at least 80 percent of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our mutual fund analysis tools, you can find out how much better you can do when adding Biotechnology Ultrasector to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Portfolio Suggestion Now

   

Portfolio Suggestion

Get suggestions outside of your existing asset allocation including your own model portfolios
All  Next Launch Module

Other Information on Investing in Biotechnology Mutual Fund

Biotechnology Ultrasector financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Ultrasector security.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios